CCR5 and systemic sclerosis: The importance of these findings to human fibrotic disease was validated by the observations that fibrocytes, CCR5, and CCR5 ligands accumulate in the fibrotic skin of SSc patients and that CSD blocks the migration of SSc monocytes toward CCR5 ligands.